Literature DB >> 31002774

Direct Detection of Tissue-Resident Bacteria and Chronic Inflammation in the Bladder Wall of Postmenopausal Women with Recurrent Urinary Tract Infection.

Nicole J De Nisco1, Michael Neugent2, Jason Mull3, Luming Chen4, Amy Kuprasertkul5, Marcela de Souza Santos4, Kelli L Palmer2, Philippe Zimmern5, Kim Orth6.   

Abstract

Urinary tract infections (UTIs) are the most commonly reported infections in adult women and have high rates of recurrence, especially in postmenopausal women. Recurrent UTI (RUTI) greatly reduces quality of life, places a significant burden on the healthcare system, and contributes to antimicrobial resistance. Because treatment of RUTI by long-term antibiotic therapy is often ineffective or poorly tolerated in elderly women, new therapies must be developed. The molecular basis of RUTI, especially in postmenopausal women, has remained unclear because modeling RUTI in mice is difficult, and human data are limited. Invasion of the urothelium and induction of host inflammation are hypothesized to be key mechanisms by which bacterial pathogens cause RUTI. To further our understanding of RUTI in humans, we performed a systematic analysis of urine and bladder biopsy samples from postmenopausal women undergoing cystoscopy with fulguration of trigonitis in the advanced management of antibiotic-refractory RUTI. We provide direct evidence that bacteria reside in the bladder wall of postmenopausal RUTI patients and that diverse bacterial species can be isolated from the bladder tissue. Histopathological scoring revealed significant edema and alterations of urothelial architecture in RUTI patient biopsies. Lymphocytes, including plasma B-cells, were detected within the mesenchyme, urothelium, and follicular aggregates in the majority of patients, indicating that the local adaptive immune response is active during human RUTI. These data provide conclusive evidence that bacteria invade the human urothelium and suggest that diverse bacterial species and the adaptive immune response play important roles in RUTI in humans.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31002774      PMCID: PMC6801050          DOI: 10.1016/j.jmb.2019.04.008

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  45 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

2.  Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract.

Authors:  Indira U Mysorekar; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-12       Impact factor: 11.205

3.  Complicated urinary tract infections.

Authors:  Paola Lichtenberger; Thomas M Hooton
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

Review 4.  The microbiome of the urinary tract--a role beyond infection.

Authors:  Samantha A Whiteside; Hassan Razvi; Sumit Dave; Gregor Reid; Jeremy P Burton
Journal:  Nat Rev Urol       Date:  2015-01-20       Impact factor: 14.432

5.  Recurrent urinary tract infections in healthy and nonpregnant women.

Authors:  Matthew Glover; Cristiano G Moreira; Vanessa Sperandio; Philippe Zimmern
Journal:  Urol Sci       Date:  2014-03

6.  Bacteriology and ultrastructure of the bladder in patients with urinary tract infections.

Authors:  T S Elliott; L Reed; R C Slack; M C Bishop
Journal:  J Infect       Date:  1985-11       Impact factor: 6.072

Review 7.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

8.  A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease.

Authors:  Valerie P O'Brien; Thomas J Hannan; Lu Yu; Jonathan Livny; Elisha D O Roberson; Drew J Schwartz; Spenser Souza; Cathy L Mendelsohn; Marco Colonna; Amanda L Lewis; Scott J Hultgren
Journal:  Nat Microbiol       Date:  2016-10-31       Impact factor: 17.745

9.  Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women.

Authors:  R Ikäheimo; A Siitonen; T Heiskanen; U Kärkkäinen; P Kuosmanen; P Lipponen; P H Mäkelä
Journal:  Clin Infect Dis       Date:  1996-01       Impact factor: 9.079

10.  Estrogen supports urothelial defense mechanisms.

Authors:  Petra Lüthje; Hanna Brauner; Nubia L Ramos; Amanda Ovregaard; Regine Gläser; Angelica Lindén Hirschberg; Pontus Aspenström; Annelie Brauner
Journal:  Sci Transl Med       Date:  2013-06-19       Impact factor: 17.956

View more
  22 in total

Review 1.  Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition.

Authors:  Larry Reitzer; Philippe Zimmern
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

Review 2.  Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies.

Authors:  Roger D Klein; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2020-02-18       Impact factor: 60.633

3.  Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice.

Authors:  Valerie P O'Brien; Matthew S Joens; Amanda L Lewis; Nicole M Gilbert
Journal:  J Vis Exp       Date:  2020-12-04       Impact factor: 1.355

4.  Gut-bladder axis enters the stage: Implication for recurrent urinary tract infections.

Authors:  Arnold M Salazar; Michael L Neugent; Nicole J De Nisco; Indira U Mysorekar
Journal:  Cell Host Microbe       Date:  2022-08-10       Impact factor: 31.316

5.  Electro-fulguration for extensive inflammatory bladder lesions in post-menopausal women with antibiotic-recalcitrant recurrent urinary tract infections.

Authors:  Rosalind Ma; Jacqueline A Chavez; Alana L Christie; Philippe E Zimmern
Journal:  Int Urogynecol J       Date:  2022-09-27       Impact factor: 1.932

6.  Ciprofloxacin Pharmacokinetics/Pharmacodynamics against Susceptible and Low-Level Resistant Escherichia coli Isolates in an Experimental Ascending Urinary Tract Infection Model in Mice.

Authors:  Lotte Jakobsen; Carina Vingsbro Lundberg; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

Review 7.  The microbiome and host mucosal interactions in urinary tract diseases.

Authors:  Bernadette Jones-Freeman; Michelle Chonwerawong; Vanessa R Marcelino; Aniruddh V Deshpande; Samuel C Forster; Malcolm R Starkey
Journal:  Mucosal Immunol       Date:  2021-02-04       Impact factor: 7.313

8.  Uropathogenic Escherichia coli Shows Antibiotic Tolerance and Growth Heterogeneity in an In Vitro Model of Intracellular Infection.

Authors:  Françoise Van Bambeke; Marta Putrinš; Ivana Kerkez; Paul M Tulkens; Tanel Tenson
Journal:  Antimicrob Agents Chemother       Date:  2021-09-27       Impact factor: 5.191

9.  Urinary prostaglandin E2 as a biomarker for recurrent UTI in postmenopausal women.

Authors:  Tahmineh Ebrahimzadeh; Amy Kuprasertkul; Michael L Neugent; Kevin C Lutz; Jorge L Fuentes; Jashkaran Gadhvi; Fatima Khan; Cong Zhang; Belle M Sharon; Kim Orth; Qiwei Li; Philippe E Zimmern; Nicole J De Nisco
Journal:  Life Sci Alliance       Date:  2021-05-06

10.  Recurrent urinary tract infection: Association of clinical profiles with urobiome composition in women.

Authors:  Lindsey A Burnett; Baylie R Hochstedler; Kelly Weldon; Alan J Wolfe; Linda Brubaker
Journal:  Neurourol Urodyn       Date:  2021-05-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.